Cialis Lifecycle Management: Lilly's BPH Dilemma

Timing of sexual activity was not restricted relative to when patients took Cialis.Results in General ED Population — The primary US efficacy and safety trial included a total of 287 patients, with a mean age of 59 years (range 25 to 82 years).

Attribute	Description	Notes
Generic Name	Tadalafil	Main active ingredient
Brand Name	Cialis (by Lilly)	Commercial name
Dosage Forms	Tablets, oral	Available forms
Typical Dose	5 mg, 10 mg, 20 mg	Varies per prescription
Onset of Action	30-60 minutes	Time to effect
Duration of Effect	Up to 36 hours	Pharmacological window

Most (>96%) patients reported ED of at least 1-year duration.The primary efficacy and safety study conducted outside the US included 268 patients, with a mean age of 56 years (range 21 to 78 years).

Related topics

Patients with multiple co-morbid conditions such as erectile dysfunction, diabetes mellitus, hypertension, and other cardiovascular disease were included.CIALIS with finasteride demonstrated statistically significant improvement in the signs and symptoms of BPH compared to placebo with finasteride, as measured by the total IPSS at 12 weeks, the primary study endpoint (see Table 20). The incremental benefit of CIALIS beyond 26 weeks is unknown.Figure 7: Mean Total IPSS Changes By Visit in BPH Patients Taking CIALIS for Once Daily Use Together With great britain drugs generic cialis FinasterideIn the 404 patients who had both ED and BPH at baseline, changes in erectile function were assessed as key secondary endpoints using the EF domain of the IIEF questionnaire. A statistically significant improvement from baseline (CIALIS/finasteride 13.7, placebo/finasteride 15.1) was observed at week 4 (CIALIS/finasteride 3.7, placebo/finasteride -1.1; p<.001), week 12 (CIALIS/finasteride 4.7, placebo/finasteride 0.6; p<.001), and week 26 (CIALIS/finasteride 4.7, placebo/finasteride 0.0; p<.001).14.4 CIALIS 5 mg for Once Daily Use for ED and BPHThe efficacy and safety of CIALIS for once daily use for the treatment of ED, and the signs and symptoms of BPH, in patients with both conditions was evaluated in one placebo-controlled, multinational, double-blind, parallel-arm study which randomized 606 patients to receive either CIALIS 2.5 mg, 5 mg, for once daily use or placebo. Patients with multiple co-morbid conditions such as diabetes mellitus, hypertension, and other cardiovascular disease were included.In this study, the co-primary endpoints were total IPSS and the Erectile Function (EF) domain score of the International Index of Erectile Function (IIEF). Timing of sexual activity was not restricted relative to when patients took CIALIS.The efficacy results for patients with both ED and BPH, who received either CIALIS 5 mg for once daily use or placebo (N=408) are shown in Tables 21 and 22 and Figure 8.CIALIS 5 mg for once daily use resulted in statistically significant improvements in the total IPSS and in the EF domain of the IIEF questionnaire.

Choose what you want

CIALIS 2.5 mg did not result in statistically significant improvement in the total IPSS.CIALIS for once daily use resulted in improvement in the IPSS total score at the first scheduled observation (week 2) and throughout the 12 weeks of treatment (see Figure 8).In this study, the effect of CIALIS 5 mg once daily on Qmax was evaluated as a safety endpoint. Read this important information before you start taking CIALIS and each time you get a refill. INGREDIENTS AND APPEARANCE Inactive IngredientsHydroxypropyl cellulose, Unspecified (UNII: 9XZ8H6N6OH)Hypromellose, Unspecified (UNII: 3NXW29V3WO)Ferric Oxide Yellow (UNII: EX438O2MRT)Lactose monohydrate (UNII: EWQ57Q8I5X)Magnesium stearate (UNII: 70097M6I30)Microcrystalline cellulose (UNII: OP1R32D61U)Sodium lauryl sulfate (UNII: 368GB5141J)Talc (UNII: 7SEV7J4R1U)Titanium dioxide (UNII: 15FIX9V2JP)Croscarmellose sodium (UNII: M28OL1HH48)Triacetin (UNII: XHX3C3X673)Product CharacteristicsColoryellowScoreno scoreShapeOVAL (almond)Size11mmFlavorImprint CodeC;10ContainsPackagingNDC:0002-4463-3030 in 1 BOTTLE; Type 0: Not a Combination Product11/26/2003Marketing InformationNDANDA02136811/26/2003CIALIStadalafil tablet, film coatedProduct InformationProduct TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:0002-4464Route of AdministrationORALActive Ingredient/Active MoietyTadalafil (UNII: 742SXX0ICT) (Tadalafil - UNII:742SXX0ICT)Tadalafil20 mgInactive IngredientsHydroxypropyl cellulose, Unspecified (UNII: 9XZ8H6N6OH)Hypromellose, Unspecified (UNII: 3NXW29V3WO)Ferric Oxide Yellow (UNII: EX438O2MRT)Lactose monohydrate (UNII: EWQ57Q8I5X)Magnesium stearate (UNII: 70097M6I30)Microcrystalline cellulose (UNII: OP1R32D61U)Sodium lauryl sulfate (UNII: 368GB5141J)Talc (UNII: 7SEV7J4R1U)Titanium dioxide (UNII: 15FIX9V2JP)Croscarmellose sodium (UNII: M28OL1HH48)Triacetin (UNII: XHX3C3X673)Product CharacteristicsColoryellowScoreno scoreShapeOVAL (almond)Size12mmFlavorImprint CodeC;20ContainsPackagingNDC:0002-4464-3030 in 1 BOTTLE; Type 0: Not a Combination Product11/26/2003Marketing InformationNDANDA02136811/26/2003Labeler - Eli Lilly and Company (006421325) Tadalafil is a medicine that is commonly used for the following conditions. Erectile dysfunction, a condition where you have trouble getting or keeping an erection Pulmonary arterial hypertension, a condition where you have high blood pressure in the blood vessels that carry blood from your heart to your lungs Benign prostatic hyperplasia (BPH), a condition where the prostate gland has become enlarged Tadalafil may also be used for other conditions as determined by your healthcare provider. Tadalafil works by blocking the activity of an enzyme called phosphodiesterase 5 (PDE5). Ninety-three percent of patients reported ED of at least 1-year duration.In each of these trials, conducted without regard to the timing of dose and sexual intercourse, CIALIS demonstrated clinically meaningful and statistically significant improvement in erectile function, as measured by the EF domain of the IIEF questionnaire and Questions 2 and 3 of the SEP diary (see Table 17). When taken as directed, CIALIS was effective at improving erectile function.In the 6 month double-blind study, the treatment effect of CIALIS did not diminish over time.Efficacy Results in ED Patients with Diabetes Mellitus — CIALIS for once daily use was shown to be effective in treating ED in patients with diabetes mellitus. In this third trial, CIALIS demonstrated clinically meaningful and statistically significant improvement in erectile function, as measured by the EF domain of the IIEF questionnaire and Questions 2 and 3 of the SEP diary (see Table 18).14.3 CIALIS 5 mg for Once Daily Use for Benign Prostatic Hyperplasia (BPH)The efficacy and safety of CIALIS for once daily use for the treatment of the signs and symptoms of BPH was evaluated in 3 randomized, multinational, double-blinded, placebo-controlled, parallel-design, efficacy and safety studies of 12 weeks duration.

Product	Dosage	Quantity + Bonus	Price
Cialis Super Active	20mg	180 + 20 Pills	521.59€ 496.75€	Buy
Cialis Professional	20mg	90 + 2 Pills	241.49€ 229.99€	Buy
Cialis Generic	20mg	180 + 10 Pills	254.09€ 241.99€	Buy
Cialis Generic	40mg	60 + 6 Pills	130.98€ 124.74€	Buy
Cialis Generic	5mg	120 + 6 Pills	132.92€ 126.59€	Buy
Cialis Professional	40mg	90 + 2 Pills	348.59€ 331.99€	Buy
Cialis Soft Tabs	20mg	90 + 6 Pills	216.71€ 206.39€	Buy
Cialis Original	20mg	12 Pills	78.32€ 74.59€	Buy
Cialis Professional	20mg	180 + 4 Pills	423.11€ 402.96€	Buy
Cialis Generic	5mg	90 + 6 Pills	115.91€ 110.39€	Buy
Cialis Black	80mg	10 Pills	43.27€ 41.21€	Buy
Cialis Original	20mg	120 + 8 Pills	497.29€ 473.61€	Buy

Patients with multiple co-morbid conditions such as diabetes mellitus, hypertension, and other cardiovascular disease were included.The primary efficacy endpoint in the two studies that evaluated the effect of CIALIS for the signs and symptoms of BPH was the International Prostate Symptom Score (IPSS), a four week recall questionnaire that was administered at the beginning and end of a placebo run-in period and subsequently at follow-up visits after randomization. Maximum urinary flow rate (Qmax), an objective measure of urine flow, was assessed as a secondary efficacy endpoint in Study J and as a safety endpoint in Study K.The results for BPH patients with moderate to severe symptoms and a mean age of 63.2 years (range 44 to 87) who received either CIALIS 5 mg for once daily use or placebo (N=748) in Studies J and K are shown in Table 19 and Figures 5 and 6, respectively.In each of these 2 trials, CIALIS 5 mg for once daily use resulted in statistically significant improvement in the total IPSS compared to placebo.

5.11 Combination With Other PDE5 Inhibitors or Erectile Dysfunction Therapies

The side effects may vary depending upon the condition being treated. Tell your healthcare provider if you have any of these side effects that bother you. Pain in your muscles, back, arms, or legs There may be other side effects of tadalafil that are not listed here. Contact your healthcare provider if you think you are having a side effect of a medicine. In the U.S., you can report side effects to the FDA at or by calling 800-FDA-1088.

Law360 is on it, so you are, too.

In Canada, you can report side effects to Health Canada at or by calling 866-234-2345. Mean total IPSS showed a decrease starting at the first scheduled observation (4 weeks) in Study K and remained decreased through 12 weeks.In Study J, the effect of CIALIS 5 mg once daily on maximum urinary flow rate (Qmax) was evaluated as a secondary efficacy endpoint.

2.6 Use in Specific Populations

Timing of sexual activity was not restricted relative to when patients took Cialis.Results in General ED Population — The primary US efficacy and safety trial included a total of 287 patients, with a mean age of 59 years (range 25 to 82 years). Most (>96%) patients reported ED of at least 1-year duration.The primary efficacy and safety study conducted outside the US included 268 patients, with a mean age of 56 years (range 21 to 78 years). Ninety-three percent of patients reported ED of at least 1-year duration.In each of these trials, conducted without regard to the timing of dose and sexual intercourse, CIALIS demonstrated clinically meaningful and statistically significant improvement in erectile function, as measured by the EF domain of the IIEF questionnaire and Questions 2 and 3 of the SEP diary (see Table 17). When taken as directed, CIALIS was effective at improving erectile function.In the 6 month double-blind study, the treatment effect of CIALIS did not diminish over time.Efficacy Results in ED Patients with Diabetes Mellitus — CIALIS for once daily use was shown to be effective in treating ED in patients with diabetes mellitus. In this third trial, CIALIS demonstrated clinically meaningful and statistically significant improvement in erectile function, as measured by the EF domain of the IIEF questionnaire and Questions 2 and 3 of the SEP diary (see Table 18).14.3 CIALIS 5 mg for Once Daily Use for Benign Prostatic Hyperplasia (BPH)The efficacy and safety of CIALIS for once daily use for the treatment of the signs and symptoms of BPH was evaluated in 3 randomized, multinational, double-blinded, placebo-controlled, parallel-design, efficacy and safety studies of 12 weeks duration.

8.5 Geriatric Use

Patients with multiple co-morbid conditions such as diabetes mellitus, hypertension, and other cardiovascular disease were included.The primary efficacy endpoint in the two studies that evaluated the effect of CIALIS for the signs and symptoms of BPH was the International Prostate Symptom Score (IPSS), a four week recall questionnaire that was administered at the beginning and end of a placebo run-in period and subsequently at follow-up visits after randomization. Maximum urinary flow rate (Qmax), an objective measure of urine flow, was assessed as a secondary efficacy endpoint in Study J and as a safety endpoint in Study K.The results for BPH patients with moderate to severe symptoms and a mean age of 63.2 years (range 44 to 87) who received either CIALIS 5 mg for once daily use or placebo (N=748) in Studies J and K are shown in Table 19 and Figures 5 and 6, respectively.In each of these 2 trials, CIALIS 5 mg for once daily use resulted in statistically significant improvement in the total IPSS compared to placebo. Mean total IPSS showed a decrease starting at the first scheduled observation (4 weeks) in Study K and remained decreased through 12 weeks.In Study J, the effect of CIALIS 5 mg once daily on maximum urinary flow rate (Qmax) was evaluated as a secondary efficacy endpoint. Mean Qmax increased from baseline in both the treatment and placebo groups (CIALIS 5 mg: 1.6 mL/sec, placebo: 1.2 mL/sec); however, these changes were not significantly different between groups.In Study K, the effect of CIALIS 5 mg once daily on Qmax was evaluated as a safety endpoint. Mean Qmax increased from baseline in both the treatment and placebo groups (CIALIS 5 mg: 1.6 mL/sec, placebo: 1.1 mL/sec); however, these changes were not significantly different between groups.Efficacy Results in Patients with BPH initiating CIALIS and Finasteride – CIALIS for once daily use initiated together with finasteride was shown to be effective in treating the signs and symptoms of BPH in men with an enlarged prostate (>30 cc) for up to 26 weeks. Mean Qmax increased from baseline in both the treatment and placebo groups (CIALIS 5 mg: 1.6 mL/sec, placebo: 1.2 mL/sec); however, these changes were not significantly different between groups.In Study K, the effect of CIALIS 5 mg once daily on Qmax was evaluated as a safety endpoint.

Parameter	Value	Details
Absorption	Rapid, within 30-120 minutes	Food intake can delay absorption
Bioavailability	~40%	Fraction of dose that enters circulation
Metabolism	Liver (CYP3A4 enzyme)	Enzymatic processing
Half-life	~17.5 hours	Duration of action in the body
Excretion	Feces (~61%), Urine (~36%)	Mainly via hepatic pathways

Mean Qmax increased from baseline in both the treatment and placebo groups (CIALIS 5 mg: 1.6 mL/sec, placebo: 1.1 mL/sec); however, these changes were not significantly different between groups.Efficacy Results in Patients with BPH initiating CIALIS and Finasteride – CIALIS for once daily use initiated together with finasteride was shown to be effective in treating the signs and symptoms of BPH in men with an enlarged prostate (>30 cc) for up to 26 weeks. Patients with multiple co-morbid conditions such as erectile dysfunction, diabetes mellitus, hypertension, and other cardiovascular disease were included.CIALIS with finasteride demonstrated statistically significant improvement in the signs and symptoms of BPH compared to placebo with finasteride, as measured by the total IPSS at 12 weeks, the primary study endpoint (see Table 20).

• Cialis dosages allow flexibility: starting doses vary per patient need.
• Low-dose daily Cialis supports continuous readiness for sexual activity.
• Higher doses are typically used for occasional use prior to intercourse.
• Cialis clinical trials involved thousands of participants worldwide.
• Lilly’s research focused on minimizing adverse effects and maximizing efficacy.
• Cialis can alleviate symptoms of BPH by relaxing bladder muscles.
• Studies confirmed Cialis improves overall sexual satisfaction scores.
• The drug has a favorable safety profile compared to some alternatives.
• Lilly Armed Cialis with extensive marketing campaigns globally.
• Patient adherence improves if side effects are well managed.
• Cialis is contraindicated in patients with severe cardiovascular disease.
• The drug is monitored for post-marketing surveillance of safety.

The incremental benefit of CIALIS beyond 26 weeks is unknown.Figure 7: Mean Total IPSS Changes By Visit in BPH Patients Taking CIALIS for Once Daily Use Together With great britain drugs generic cialis FinasterideIn the 404 patients who had both ED and BPH at baseline, changes in erectile function were assessed as key secondary endpoints using the EF domain of the IIEF questionnaire. A statistically significant improvement from baseline (CIALIS/finasteride 13.7, placebo/finasteride 15.1) was observed at week 4 (CIALIS/finasteride 3.7, placebo/finasteride -1.1; p<.001), week 12 (CIALIS/finasteride 4.7, placebo/finasteride 0.6; p<.001), and week 26 (CIALIS/finasteride 4.7, placebo/finasteride 0.0; p<.001).14.4 CIALIS 5 mg for Once Daily Use for ED and BPHThe efficacy and safety of CIALIS for once daily use for the treatment of ED, and the signs and symptoms of BPH, in patients with both conditions was evaluated in one placebo-controlled, multinational, double-blind, parallel-arm study which randomized 606 patients to receive either CIALIS 2.5 mg, 5 mg, for once daily use or placebo. Patients with multiple co-morbid conditions such as diabetes mellitus, hypertension, and other cardiovascular disease were included.In this study, the co-primary endpoints were total IPSS and the Erectile Function (EF) domain score of the International Index of Erectile Function (IIEF). Timing of sexual activity was not restricted relative to when patients took CIALIS.The efficacy results for patients with both ED and BPH, who received either CIALIS 5 mg for once daily use or placebo (N=408) are shown in Tables 21 and 22 and Figure 8.CIALIS 5 mg for once daily use resulted in statistically significant improvements in the total IPSS and in the EF domain of the IIEF questionnaire. CIALIS 2.5 mg did not result in statistically significant improvement in the total IPSS.CIALIS for once daily use resulted in improvement in the IPSS total score at the first scheduled observation (week 2) and throughout the 12 weeks of treatment (see Figure 8).In this study, the effect of CIALIS 5 mg once daily on Qmax was evaluated as a safety endpoint. Read this important information before you start taking CIALIS and each time you get a refill.

5.1 Cardiovascular

This enzyme usually stops some types of muscles from relaxing, including the muscles lining some types of blood vessels. By blocking PDE5, the muscles will relax and blood flow increases. For erectile dysfunction, it increases blood flow to the penis when aroused. This makes it easier to get and keep an erection. For pulmonary arterial hypertension, tadalafil relaxes the blood vessels in the lungs.

Millions of orders

This lowers blood pressure and reduces strain on the heart. For benign prostatic hyperplasia, tadalafil relaxes the muscles of the bladder and prostate, making it easier to urinate and reducing symptoms. Tadalafil should be stored at room temperature, between 68 F to 77 F (20 C cheap cialis soft tabs to 25 C). It can be exposed to temperatures between 59 F to 86 F (15 C to 30 C) for shorter periods of time, such as when transporting it. The most common side effects of tadalafil are listed below. INGREDIENTS AND APPEARANCE Inactive IngredientsHydroxypropyl cellulose, Unspecified (UNII: 9XZ8H6N6OH)Hypromellose, Unspecified (UNII: 3NXW29V3WO)Ferric Oxide Yellow (UNII: EX438O2MRT)Lactose monohydrate (UNII: EWQ57Q8I5X)Magnesium stearate (UNII: 70097M6I30)Microcrystalline cellulose (UNII: OP1R32D61U)Sodium lauryl sulfate (UNII: 368GB5141J)Talc (UNII: 7SEV7J4R1U)Titanium dioxide (UNII: 15FIX9V2JP)Croscarmellose sodium (UNII: M28OL1HH48)Triacetin (UNII: XHX3C3X673)Product CharacteristicsColoryellowScoreno scoreShapeOVAL (almond)Size11mmFlavorImprint CodeC;10ContainsPackagingNDC:0002-4463-3030 in 1 BOTTLE; Type 0: Not a Combination Product11/26/2003Marketing InformationNDANDA02136811/26/2003CIALIStadalafil tablet, film coatedProduct InformationProduct TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:0002-4464Route of AdministrationORALActive Ingredient/Active MoietyTadalafil (UNII: 742SXX0ICT) (Tadalafil - UNII:742SXX0ICT)Tadalafil20 mgInactive IngredientsHydroxypropyl cellulose, Unspecified (UNII: 9XZ8H6N6OH)Hypromellose, Unspecified (UNII: 3NXW29V3WO)Ferric Oxide Yellow (UNII: EX438O2MRT)Lactose monohydrate (UNII: EWQ57Q8I5X)Magnesium stearate (UNII: 70097M6I30)Microcrystalline cellulose (UNII: OP1R32D61U)Sodium lauryl sulfate (UNII: 368GB5141J)Talc (UNII: 7SEV7J4R1U)Titanium dioxide (UNII: 15FIX9V2JP)Croscarmellose sodium (UNII: M28OL1HH48)Triacetin (UNII: XHX3C3X673)Product CharacteristicsColoryellowScoreno scoreShapeOVAL (almond)Size12mmFlavorImprint CodeC;20ContainsPackagingNDC:0002-4464-3030 in 1 BOTTLE; Type 0: Not a Combination Product11/26/2003Marketing InformationNDANDA02136811/26/2003Labeler - Eli Lilly and Company (006421325) Tadalafil is a medicine that is commonly used for the following conditions.

8. Use In Specific Populations

Erectile dysfunction, a condition where you have trouble getting or keeping an erection Pulmonary arterial hypertension, a condition where you have high blood pressure in the blood vessels that carry blood from your heart to your lungs Benign prostatic hyperplasia (BPH), a condition where the prostate gland has become enlarged Tadalafil may also be used for other conditions as determined by your healthcare provider. Tadalafil works by blocking the activity of an enzyme called phosphodiesterase 5 (PDE5). This enzyme usually stops some types of muscles from relaxing, including the muscles lining some types of blood vessels. By blocking PDE5, the muscles will relax and blood flow increases. For erectile dysfunction, it increases blood flow to the penis when aroused.

• Cialis was approved by the European Medicines Agency (EMA).
• It is widely available in pharmacies and hospitals.
• Cialis’s trademark is owned by Eli Lilly and Company.
• Generic tadalafil requires prescribed substitution where allowed.
• Lilly offers risk management programs for Cialis use.
• Insurance coverage for Cialis varies by country and plan.
• Cialis is not suitable for females and children.
• Studies show Cialis maintains efficacy with chronic use.
• Lilly invested in advertising campaigns emphasizing Cialis’s long action.
• The company collaborates with healthcare providers for education.
• Cialis’s sales contribute significantly to Lilly’s revenue.
• Scientific journals publish continuous data on Cialis’s effectiveness.

This makes it easier to get and keep an erection. For pulmonary arterial hypertension, tadalafil relaxes the blood vessels in the lungs.

Region	Typical Price per Tablet	Availability
United States	$15 - $30	Widely available
Europe	€12 - €25	Available via prescription
Asia	$8 - $20	Over-the-counter in some countries
Australia	AUD 20 - AUD 40	Prescription required
Online pharmacies	Varies	Check for legitimacy

This lowers blood pressure and reduces strain on the heart. For benign prostatic hyperplasia, tadalafil relaxes the muscles of the bladder and prostate, making it easier to urinate and reducing symptoms. Tadalafil should be stored at room temperature, between 68 F to 77 F (20 C cheap cialis soft tabs to 25 C). It can be exposed to temperatures between 59 F to 86 F (15 C to 30 C) for shorter periods of time, such as when transporting it. The most common side effects of tadalafil are listed below. The side effects may vary depending upon the condition being treated. Tell your healthcare provider if you have any of these side effects that bother you. Pain in your muscles, back, arms, or legs There may be other side effects of tadalafil that are not listed here. Contact your healthcare provider if you think you are having a side effect of a medicine. In the U.S., you can report side effects to the FDA at or by calling 800-FDA-1088.

• Cialis prescription guidelines emphasize age and health status evaluation.
• The medication is contraindicated in men advised against sexual activity.
• Prior to Cialis, medical history should be reviewed thoroughly.
• Cialis enables more spontaneous and confidence-building intimacy.
• Treatment success is higher with proper adherence to dosing schedules.
• Patient-reported outcome measures monitor Cialis effectiveness.
• Cialis has been featured in numerous clinical practice guidelines.
• Fertility effects of Cialis have been studied but show no major risk.
• The drug is usually well tolerated across diverse populations.
• Treatment discontinuation can occur due to side effects or lack of efficacy.
• Lilly offers educational resources for healthcare professionals.
• Cialis complements lifestyle modification for ED treatment.

In Canada, you can report side effects to Health Canada at or by calling 866-234-2345.